Lung Cancer

The combination of Keytruda plus chemoradiotherapy induced a ‘promising’ 12-month progression-free survival rate in patients with locally advanced non-small cell lung cancer.

The Food and Drug Administration granted a priority review to the new drug application for lurbinectedin to treat patients with small cell lung cancer.

The Food and Drug Administration granted a final approval to pemfexy, a branded alternative chemotherapy injection for patients with advanced or metastatic nonsquamous non-small cell lung cancer, potentially offering them a cheaper treatment option in the future.

By taking part in a new survey series, patients with lung cancer can shed light on their quality of life and help drive research.

From thousands of patients with breast cancer told to be re-checked after a surgeon performed botched surgeries to three young brothers receiving the same eye cancer diagnosis, here’s what is making headlines in the cancer space this week.

The Food and Drug Administration approved chemotherapy injection Pemfexy for the treatment of patients with nonsquamous non-small cell lung cancer.
 

From actress Shannen Doherty announcing she will continue to fight her stage 4 breast cancer to the Food and Drug Administration’s first hearing on asbestos testing in talc in 50 years, here’s what is making headlines in the cancer space this week.

Disparities exist around the globe when it comes to understanding cancer risk factors and prevention measures.

In a first-of-its-kind analysis, researchers found that high body mass index may be associated with improved survival in Tecentriq-treated patients with advanced non–small cell lung cancer.